Compound Detail
CHEMBL4862632
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1ccc(-c2cc(=O)oc3c(C)c(OCC(=O)N[C@@H](Cc4c[nH]c5ccc(O)cc45)C(=O)O)ccc23)cc1
Basic Information
| ChEMBL ID | CHEMBL4862632 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CFRMMCCRNKCUIX-VWLOTQADSA-N |
2
Targets
2
Activities
2
Assay Types
1
PK Parameters
3
Publications
0
Known Names
Molecular Properties
542.5
MW (Da)
4.15
ALogP
7
HBA
4
HBD
151.1
PSA (Ų)
0.20
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.94
Kd 1 meas. best 6.58
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Ka | 5.65 | 10^5/M/s | Staphylococcus aureus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MecA | Kd | = | 264.0 | nM | 6.58 | Binding affinity to Staphylococcus aureus PBP2a assessed as equilibrium dissocia... | 33811991 |
| L02 | IC50 | = | 11600.0 | nM | 4.94 | Cytotoxicity against human LO2 cells | 33811991 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33811991 | 10.1016/j.bmcl.2021.128001 | MecA | 3 |
| 33811991 | 10.1016/j.bmcl.2021.128001 | Staphylococcus aureus | 2 |
| 33811991 | 10.1016/j.bmcl.2021.128001 | L02 | 1 |
Data from ChEMBL 36 via Core Engine